|
HS Code |
499000 |
| Name | 2,4-Dibromoiodobenzene |
| Cas Number | 2929-21-5 |
| Molecular Formula | C6H3Br2I |
| Molecular Weight | 372.81 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 89-91 °C |
| Density | 2.49 g/cm³ (estimated) |
| Solubility In Water | Insoluble |
| Smiles | C1=CC(=C(C=C1Br)I)Br |
| Inchi | InChI=1S/C6H3Br2I/c7-4-1-2-6(9)5(8)3-4/h1-3H |
| Pubchem Cid | 67441 |
As an accredited 2,4-Dibromoiodobenzene factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2,4-Dibromoiodobenzene prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
2,4-Dibromoiodobenzene might not be a household name, but in the chemistry world, it’s got a reputation for being robust and reliable. This compound brings together bromine and iodine in a way that creates a lot of potential for those working in advanced organic synthesis or small-scale research labs. The kind of satisfaction chemists get from using a specialized building block like this goes beyond just “getting the job done.” It’s about having the right tool when nothing else quite matches up.
This compound has earned fans among researchers who care about precision and repeatability. Whether you're tinkering with new molecular frameworks or scaling up for pilot projects, the backbone of 2,4-Dibromoiodobenzene—modeled as C6H3Br2I—has become a reliable bridge to more complex architectures. With a melting point high enough to survive rigorous lab work, there's a reassurance that comes from knowing this substance won’t break down or give odd interference during crucial reactions. The dual bromine atoms and single iodine atom placed on the benzene ring open up selective coupling possibilities that broader halogenated benzenes can’t always manage.
Over the years, people I’ve met in synthetic organic chemistry have praised this compound. Some find it especially helpful for Suzuki-Miyaura coupling reactions, where precision in halogen positioning translates to better yields and fewer side products. The high purity—often above 97%—gives confidence, especially for medical research or electronics applications. When it’s about crafting molecules for new drug candidates or OLED display materials, stray contaminants can set back projects or throw data out the window. These specific attributes mean researchers spend less time troubleshooting and more time breaking fresh ground.
Iodine and bromine both serve as excellent leaving groups, letting this reagent participate in a range of cross-coupling and substitution reactions. This sets 2,4-Dibromoiodobenzene apart when compared to mono-halogenated or symmetrical tri-halogenated benzenes. The unique arrangement of halogens grants predictable regioselectivity, allowing for stepwise functionalization. Time after time, these features turn a straightforward reagent into a go-to workhorse in any diverse chemical toolkit.
Plenty of halogenated aromatics compete for lab space, but not many can replicate the strengths found here. Some researchers use iodobenzene or bromobenzene for basic reactions, but these single-halogen options can’t offer the same control. Their reactivity opens doors to straightforward transformations, but there’s less nuance for tailoring function. 2,4-Dibromoiodobenzene lets chemists map out multi-step syntheses with higher selectivity. Getting both bromine and iodine into the process lets a chemist plan precise substitution steps. That way, you don't sacrifice reactivity for control.
Other halogenated benzenes—like 2,4,6-tribromoiodobenzene—carry more loaded rings, but extra halogens often create problems. Higher halogen density not only bumps toxicity but sometimes clogs up downstream reactions, leading to complicated purification or wasted materials. In contrast, 2,4-Dibromoiodobenzene lands a sweet spot: enough functionality for creative chemistry, not so much as to overload or muddy a synthesis. Users have shared stories of failed reactions with more heavily halogenated aromatics that managed to succeed once they switched to this particular structure.
I’ve watched colleagues in the pharmaceutical sector build libraries of new compounds with this reagent. Its tailored reactivity supports modular synthesis—a critical approach when teams want to rapidly generate analogs for testing. For anything from kinase inhibitors to antimicrobial agents, the efficiency savings alone have a real-world ripple effect. With the classic Suzuki, Sonogashira, and Stille reactions, teams move more quickly from idea to reality. They avoid complex protection and deprotection steps, which can quickly balloon lab hours and costs.
In the world of material science, properties like thermal stability and electronic configuration come into play. 2,4-Dibromoiodobenzene blends both worlds: the electronic pull from its heavy halogens affects both π-π stacking and electron density, opening up new design space for organic semiconductors, photovoltaic materials, or advanced polymers. I’ve seen patent filings grow steadily as teams explore new uses. These opportunities wouldn’t exist without access to reagents tailored for high selectivity during synthesis and clean elimination during processing.
Substances like 2,4-Dibromoiodobenzene demand a measured, respectful approach. You don’t get far in synthetic chemistry without coming across tools that push boundaries. There’s a reason lab safety protocols highlight proper storage, ventilation, and PPE—bromine and iodine compounds don’t just mix with anything. Responsible handling isn’t just about following rules; it’s about making sure innovative work continues without interruption or risk of contamination. Solid, granular forms make weighing straightforward, but each batch still calls for double-checking purity by NMR or chromatography. Taking shortcuts with quality control comes back to haunt researchers, so a focus on well-characterized product matters from the bench to the production scale.
Sourcing reliable chemicals, as I’ve learned, often boils down to trusted suppliers and consistent documentation. Many labs opt for suppliers with traceable batch certificates. They’ll only buy after checking third-party analyses. There’s wisdom in sharing best practices among collaborators, since cross-border sourcing can bring surprises. Knowledge about shipping, customs, and local regulations for hazardous chemicals keeps projects running on schedule and compliance headaches to a minimum.
What’s become clear is that science doesn’t move forward with off-the-shelf answers alone. Research projects evolve, and requirements in synthesis shift. One group might explore new ligands for palladium-catalyzed reactions, while another group hunts for ways to lower waste in industrial runs. The features found in 2,4-Dibromoiodobenzene cater to these evolving needs. As a modular intermediate, it supports both flexibility and repeatability. Integrated into more comprehensive supply chains, its dependability saves both time and money across a range of projects.
It’s somewhat remarkable how much progress rides on specialty building blocks. Without them, many avenues in medicinal or material chemistry would narrow or disappear entirely. Looking at the body of published research and patents, the continued use of this compound stands out. Applications in catalysis, molecular electronics, and surface chemistry have all leaned on its structure and reactivity. The pace of discovery depends in part on bridging basic chemistry with demanding applied research. Well-placed intermediates like 2,4-Dibromoiodobenzene bridge that gap.
Anyone serious about synthetic strategy knows that moving from a simple aromatic ring to a fully functionalized molecule isn’t just a point-and-click task. The right starting material cuts down on steps and improves both cost and environmental impact. By setting up two bromines and one iodine, chemists choose which halogen leaves the ring and which ones stay to take part in further chemistry. This kind of selectivity leads to fewer by-products and cleaner separations, giving those in analytical roles less headache during purification. Less time in the cleanup phase means more capacity to run reactions or test new ideas.
This compound also fits into broader efforts to “green” chemistry. Careful selection, high purity, and controlled reactivity mean less solvent use, fewer harsh reagents, and reduced energy inputs. Although not always framed as a sustainability tool, any advance that lets labs use less material and generate less waste builds toward responsible research. In larger scale applications, this effect multiplies. Labs looking to decrease their environmental footprint frequently re-examine their building blocks, and compounds like 2,4-Dibromoiodobenzene often come out ahead.
People who have switched from generic halogenated benzenes to 2,4-Dibromoiodobenzene often talk about stronger yields and more predictable downstream results. Sometimes, the stories are about how a new reaction came together after months of troubleshooting. Other times, it’s about meeting safety or patentability requirements for a drug development pipeline. It all adds up to one point: having access to targeted reagents shapes project success rates.
These outcomes carry weight beyond one lab session. Startups in the biopharmaceutical space, for instance, operate on razor-thin margins. They can’t afford to wait too long for results or burn through budgets cleaning up impure products. Streamlined synthesis routes powered by dependable intermediates get teams to proof-of-concept or regulatory filings faster. Materials scientists echo similar feedback: time saved during one stage of development can unlock earlier entry to market for a new conductive polymer or sensor.
From my own work, daily choices about which reagents to use don’t boil down just to availability or cost—they rest on confidence that the chemistry will hold up under scrutiny. Running simple test reactions with a fresh batch of 2,4-Dibromoiodobenzene becomes a quick way to gauge whether a supplier’s quality matches published standards. If a coupling reaction runs poorly, the issue often traces back to off-spec material—something that shows up as lingering spots on TLC plates or odd peaks in HPLC traces.
The difference between smooth and rocky syntheses often starts with the building block. Reliable supply keeps teams moving. Labs that keep backups can dodge delays from disrupted shipping or rare market tightness. Teams running larger scale-ups may store intermediates at low temperatures and monitor for decomposition or moisture uptake. Simple habits like these count for more than people realize when deadlines approach.
This chemical, like others with high reactivity, holds the potential for both innovation and risk. Researchers and organizations have to manage its use in ways that uphold both scientific integrity and legal standards. Oversight starts early—procurement involves clear documentation, and health and safety briefings cover risk reduction. Waste disposal procedures are set up in advance, protecting people, data, and the environment. This sense of stewardship encourages responsible experimentation and fosters trust in research findings.
Ethical use ties directly into the wider goal of making science work for society. Whether a team is crafting next-generation sensors, potential treatments for disease, or stronger semiconducting films, the public counts on scientists to balance innovation with caution. Clear records, shared best practices, and mentorship in labs make a big difference in safe outcomes for both researchers and end users.
Looking back at progress in chemical synthesis, many leaps didn’t start with bold announcements—they came from small tweaks to reagents or fresh combinations of familiar building blocks. 2,4-Dibromoiodobenzene serves as an example of this incremental advancement. Its role across multiple reaction types keeps research diverse and drives the development of innovative materials and medicines. As synthetic methods evolve, so do the demands on starting materials, creating a cycle of challenge and opportunity in the chemical supply chain.
The ongoing push toward miniaturization in electronics and tighter specificity in pharmaceuticals means intermediates like this one only become more essential. Tighter regulatory regimes don’t just mean more paperwork; they mean every batch must be even more rigorously checked and documented. Labs that invest in supply quality avoid setbacks that could erode both budgets and reputation. The value of a trusted intermediate extends long after the first reaction—a lesson repeated in annual research audits and industry case studies.
One thing I’ve learned is that even tools with specific uses eventually find new roles as research questions evolve. The landscape in both academia and industry keeps changing, and flexibility pays off. 2,4-Dibromoiodobenzene has survived the shift toward automation and digital tracking because it meets a dual need: dependable chemistry and the capacity to adapt to new synthetic targets. Automation hasn’t crowded out demand; if anything, having practical intermediates has made it simpler to feed high-throughput machines that churn through hundreds of reactions.
Many core advantages don’t just live in the numbers on a spec sheet. They show up in productivity gains, in fewer failures, and ultimately, in the momentum of discovery. Anyone chasing new reactions, clearer data, or stable scale-up processes will continue reaching for reagents that perform and adapt. Even as some research turns to AI-based synthetic planning or greener processes, a solid foundation in reliable chemistry still shapes outcomes in labs everywhere.
Every chemical presents its challenges. For some, it’s about sourcing or purity, for others, safe handling regulations. 2,4-Dibromoiodobenzene isn’t immune. Steps like regularly checking suppliers, investing in in-house analytical testing, and keeping well-documented SOPs matter. This routine maintenance creates smoother scale-up and fewer surprises down the line. If cost pressures heat up, consortia purchasing or collective bargaining with suppliers sometimes help smaller labs maintain access without sacrificing quality.
A common stumbling block is inconsistent loading during automated synthesis. Tuning dispensing systems and regularly calibrating balances enables more reliable high-throughput runs. Communication between teams—chemical suppliers, analytical labs, and synthetic chemists—often resolves technical hiccups. In broader terms, building a culture of transparency allows both setbacks and breakthroughs to drive improvements in workflows, rather than staying hidden.
The world of chemical research moves quickly. Teams need reagents they can count on, across both routine and specialized reactions. 2,4-Dibromoiodobenzene has cemented a unique position for itself through attributes that balance reactivity, selectivity, and practical handling. Its ongoing role in academic and industrial research highlights both the achievements and the discipline of the wider chemistry community: progress comes from persistent innovation, paired with rigorous standards and responsible use.
The feedback from scientists and the growing list of successful syntheses shows that small improvements in tools can spark big changes in what’s possible. As chemistry continues to intersect with medicine, materials, and technology, building blocks like 2,4-Dibromoiodobenzene keep powerful ideas within reach. This tradition of development, rooted in practical experience and careful adaptation, keeps science vibrant and capable of meeting new challenges head-on.